Advanced Proteome Therapeutics Corporation appointed Mr. Cory Brandolini to the board of directors. Mr. Brandolini has over 3 decades of experience in the capital markets and as an advisor to disruptive, high growth software companies across many verticals in the technology sector. Over the course of his career, he has helped raise hundreds of millions of dollars for public and private companies specifically in the technology sector.

Mr. Brandolini's background includes two decades spent in the investment industry. Mr. Brandolini was the Founder, CEO and Chairman of RESAAS Services Inc., an award-winning global real estate cloud platform. Under his direction, RESAAS saw its growth phase from a raw start up to over 400,000 subscribing realtors worldwide including the biggest brands in real estate.

Mr. Brandolini took RESAAS public as one of the first true IPOs on the Canadian Securities Exchange and assisted the company in raising over $30 million in investment. Most recently, Mr. Brandolini is the Co-Founder, President and CEO of Railtown AI Technologies Inc., developers of a SAAS-delivered solution for software development teams that utilizes AI to drive optimizations and deliver insights at every stage of software development. Railtown converts CI/CD systems to full CI/CD/CM (continuous monitoring) systems - monitor, diagnose, and prioritize errors from the whole CI/CD environment on a single platform.

Railtown's Continuous Machine Learning Application will empower developers to accelerate innovation while ensuring their applications reliability and increasing velocity. Additionally, he has continued to provide capital markets and M&A advisory services to technology companies, including Teleo (VoIP platform acquired by Microsoft), WISR (Artificial Intelligence Incubator), AuthenTicket (Ticket Verification Technology).